National Jewish Health Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT01651442
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

trazodone (desyrel) (1 trial)

zolpidem (ambien) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mental Disorders (Phase 4)

Problem Behavior (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2